Group One Trading’s Vaccinex, Inc. Common Stock VCNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-67
Closed -$231 – 8130
2024
Q3
$231 Hold
67
– – ﹤0.01% 6447
2024
Q2
$438 Hold
67
– – ﹤0.01% 6465
2024
Q1
$496 Buy
67
+2
+3% +$17 ﹤0.01% 6739
2023
Q4
$609 Hold
65
– – ﹤0.01% 7061
2023
Q3
$1.03K Sell
65
-17
-21% -$864 ﹤0.01% 7206
2023
Q2
$6.13K Sell
82
-7
-8% -$582 ﹤0.01% 6628
2023
Q1
$7.46K Sell
89
-11
-11% -$1.21K ﹤0.01% 6102
2022
Q4
$13.5K Hold
100
– – ﹤0.01% 5864
2022
Q3
$10K Buy
100
+74
+285% +$14.5K ﹤0.01% 6525
2022
Q2
$6K Buy
26
+3
+13% +$767 ﹤0.01% 7047
2022
Q1
$6K Buy
23
+17
+283% +$4.7K ﹤0.01% 7414
2021
Q4
$1K Buy
+6
New +$2.16K ﹤0.01% 8055
2021
Q1
– Hold
0
– – – 8128
2020
Q4
– Hold
0
– – – 7113

Other funds holding VCNX

Group One Trading's VCNX Position: Q4 2024 in Review

Group One Trading sold out of Vaccinex, Inc. Common Stock (VCNX) in Q4 2024, closing a stake of 67 shares — an estimated $231 sold.

Group One Trading first reported a position in VCNX in Q4 2021 and held it in 12 quarters. The position peaked at $13.5K in Q4 2022. 1 fund tracked by Wall St. Rank holds VCNX as of Q4 2024.

  • Group One Trading reported no remaining Vaccinex, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Group One Trading sold 67 Vaccinex, Inc. Common Stock shares in Q4 2024, an estimated $231.
  • Group One Trading first reported a position in Vaccinex, Inc. Common Stock in Q4 2021 and held it in 12 quarters.
  • Group One Trading's Vaccinex, Inc. Common Stock position peaked at $13.5K in Q4 2022.
  • 1 fund tracked by Wall St. Rank held Vaccinex, Inc. Common Stock as of Q4 2024.

Based on Group One Trading's 13F filing for Q4 2024, filed 14 Feb 2025.